The decision may have been made to avoid regulation by the FDA, according to BuzzFeed.
"Advanced biotracking sensors would have made the Apple Watch less of a multipurpose consumer device and more of a medical device used to diagnose diseases or track chronic conditions — which could have opened the watch up to regulation by the U.S. Food and Drug Administration.
'I don’t think Apple wants to be a health-monitoring device maker,' said Harry Wang, director of health and mobile product research at Parks Associates. 'They do want to leverage their popularity on the iPhone as a device platform, integrating all health data that can be collected for different devices.'"
From the article "The Apple Watch Is Scaling Back Its Health Features" by Ian Servantes.
According to the latest U.S. smartphone market share numbers from Parks Associates, Apple is still well in the lead compared to competing manufacturers, holding a beefy 40% of the smartphone market. B...
According to the Parks Associates survey, 55 percent of Americans with at least one chronic condition aren’t speaking with their primary care physician any more than once every three months. What’s wo...
The vast majority of fitness tracker and smartwatch owners in the United States use their wearables on a daily basis, according to the latest study from Parks Associates. Approximately 68-percent of f...
In addition, the device's interoperability will be important. According to a recent study by Parks Associates and reported in Retail Dive, 75% of consumers who plan to buy a smart home device believe...
